Aquinox Pharma (AQXP) Announces Completion of AQX-1125 Phase 2 KINSHIP Enrollment
Tweet Send to a Friend
Aquinox Pharma (NASDAQ: AQXP) announced that it has reached its target enrollment in the Phase 2 KINSHIP trial of AQX-1125 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
